CIBC Private Wealth Group
PRME icon

CIBC Private Wealth Group’s Prime Medicine PRME Stock Holding History

CIBC Private Wealth Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$926 Buy
+267
New +$1.19K ﹤0.01% 2932

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group's PRME Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Prime Medicine (PRME) in Q4 2025: 267 shares worth $926. The stake represents ﹤0.01% of the portfolio and ranks #2932 among its holdings.

183 funds tracked by Wall St. Rank hold PRME as of Q4 2025.

  • CIBC Private Wealth Group held 267 shares of Prime Medicine worth $926 as of Q4 2025.
  • Prime Medicine was a new CIBC Private Wealth Group position in Q4 2025.
  • Prime Medicine made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2932 holding.
  • 183 funds tracked by Wall St. Rank held Prime Medicine as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.